1 false false false false false false false false false false true false false false false false false No description of principal activity 2024-04-01 Sage Accounts Production Advanced 2023 - FRS102_2023 xbrli:pure xbrli:shares iso4217:GBP 14742175 2024-04-01 2024-12-31 14742175 2024-12-31 14742175 2024-03-31 14742175 bus:Director1 2024-04-01 2024-12-31 14742175 core:WithinOneYear 2024-12-31 14742175 core:AfterOneYear 2024-12-31 14742175 bus:Micro-entities 2024-04-01 2024-12-31 14742175 bus:AuditExemptWithAccountantsReport 2024-04-01 2024-12-31 14742175 bus:SmallCompaniesRegimeForAccounts 2024-04-01 2024-12-31 14742175 bus:PrivateLimitedCompanyLtd 2024-04-01 2024-12-31 14742175 bus:FullAccounts 2024-04-01 2024-12-31
COMPANY REGISTRATION NUMBER: 14742175
GAPMED LTD
Filleted Unaudited Financial Statements
31 December 2024
GAPMED LTD
Statement of Financial Position
31 December 2024
Period from
1 Apr 24 to
31 Dec 24
£
£
Fixed assets
93,750
--------
Current assets
1,729
Creditors: amounts falling due within one year
2,000
--------
Net current liabilities
( 271)
--------
Total assets less current liabilities
93,479
Creditors: amounts falling due after more than one year
115,102
---------
(21,623)
---------
Capital and reserves
( 21,623)
--------
Notes to the financial statements
1. Employee numbers
The average number of persons employed by the company during the period amounted to 1 .
For the period ending 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the period in question in accordance with section 476 ;
- The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements have been prepared in accordance with the micro-entity provisions and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
These financial statements were approved by the board of directors and authorised for issue on 14 March 2025 , and are signed on behalf of the board by:
Ms E Costello
Director
Company registration number: 14742175
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is Ground Floor Rankin Building, 139 -143 Bermondsey Street, London, SE1 3UW, England.